F5 and autoimmune polyendocrinopathy: While factor V Leiden mutation has been variably reported in APS cohorts, with some studies indicating only a modest increase in thrombotic risk and others demonstrating a significant association, especially in patients positive for lupus anticoagulant, with an estimated 7.3-fold increase [12-14].